SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437786-18-000037
Filing Date
2018-05-03
Accepted
2018-05-03 08:36:42
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imdz331201810-q.htm 10-Q 932098
2 EXHIBIT 31.1 ex311imdz2018q1.htm EX-31.1 7999
3 EXHIBIT 31.2 ex312imdz2018q1.htm EX-31.2 8112
4 EXHIBIT 32.1 ex321imdz2018q1.htm EX-32.1 4854
5 EXHIBIT 32.2 ex322imdz2018q1.htm EX-32.2 5106
  Complete submission text file 0001437786-18-000037.txt   4509046

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imdz-20180331.xml EX-101.INS 811701
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20180331.xsd EX-101.SCH 39155
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20180331_cal.xml EX-101.CAL 61423
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20180331_def.xml EX-101.DEF 168250
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20180331_lab.xml EX-101.LAB 511413
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20180331_pre.xml EX-101.PRE 288178
Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 18801914
SIC: 2834 Pharmaceutical Preparations